Showing results (421-430 of 2,113) with videos related to
Sort By:
Pageof 212
Current Pharmaceutical Design|December 15, 2015
An Update on Natural Products with Carbonic Anhydrase Inhibitory ActivityAnastasia Karioti, Fabrizio Carta, Claudiu T SupuranThe Enzymes|November 14, 2025
HIV protease and its inhibitionStefano Rusconi, Niccolò Paoletti, Claudiu T SupuranEuropean Journal of Medicinal Chemistry|April 23, 2025
Redesigning oxazolidinones as carbonic anhydrase inhibitors against vancomycin-resistant enterococciAndrea Ammara, Simone Giovannuzzi, Alessandro Bonardi, et al.Chemical Biology & Drug Design|April 10, 2025
A Journey Around Boronic Acids: Sulfonyl Hydrazone-Containing Derivatives as Carbonic Anhydrase InhibitorsDeniz A Anakök, Andrea Angeli, Ilaria D'Agostino, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|June 2, 2017
Inhibition of the α-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moietiesDaniela De Vita, Andrea Angeli, Fabiana Pandolfi, et al.European Journal of Medicinal Chemistry|March 5, 2021
Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitorsMoataz Shaldam, Wagdy M Eldehna, Alessio Nocentini, et al.European Journal of Medicinal Chemistry|October 31, 2025
Production, crystallographic studies, and functional profiling of γ-carbonic anhydrase from the probiotic Limosilactobacillus reuteri: In vitro and cell-based insightsAlessandro Bonardi, Simone Carradori, Niccolò Paoletti, et al.International Journal of Molecular Sciences|January 23, 2020
Evaluation of Thio- and Seleno-Acetamides Bearing Benzenesulfonamide as Inhibitor of Carbonic Anhydrases from Different Pathogenic BacteriaAndrea Angeli, Mariana Pinteala, Stelian S Maier, et al.Bioorganic & Medicinal Chemistry|January 1, 2026
Targeting microbial β-CAs: bridging in silico screening with in vitro validationAnna Rita Tondo, Marialuigia Fantacuzzi, Simone Carradori, et al.RSC Medicinal Chemistry|July 14, 2025
Pegylation approach applied to erlotinib-carbonic anhydrase inhibitors hybrids towards anticancer agentsSerena Filiberti, Gioele Renzi, Fabrizio Carta, et al.Pageof 212